177 related articles for article (PubMed ID: 15376198)
1. Adenocarcinoma in situ of the uterine cervix: screening and diagnostic errors in Papanicolaou smears.
Ruba S; Schoolland M; Allpress S; Sterrett G
Cancer; 2004 Oct; 102(5):280-7. PubMed ID: 15376198
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma in situ of the cervix.
Schoolland M; Segal A; Allpress S; Miranda A; Frost FA; Sterrett GF
Cancer; 2002 Dec; 96(6):330-7. PubMed ID: 12478680
[TBL] [Abstract][Full Text] [Related]
3. Comparative sensitivities of ThinPrep and Papanicolaou smear for adenocarcinoma in situ (AIS) and combined AIS/high-grade squamous intraepithelial lesion (HSIL): comparison with HSIL.
Roberts JM; Thurloe JK
Cancer; 2007 Dec; 111(6):482-6. PubMed ID: 17969065
[TBL] [Abstract][Full Text] [Related]
4. Atypical endocervical glandular cells: accuracy of cytologic diagnosis.
Lee KR; Manna EA; St John T
Diagn Cytopathol; 1995 Oct; 13(3):202-8. PubMed ID: 8575278
[TBL] [Abstract][Full Text] [Related]
5. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
7. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
[TBL] [Abstract][Full Text] [Related]
8. Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix.
Srisomboon S; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2019 Feb; 20(2):377-382. PubMed ID: 30803195
[TBL] [Abstract][Full Text] [Related]
9. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
10. Cytologic characteristics of abnormal cells in prior "normal" cervical/vaginal Papanicolaou smears from women with a high grade squamous intraepithelial lesion.
Montes MA; Cibas ES; DiNisco SA; Lee KR
Cancer; 1999 Apr; 87(2):56-9. PubMed ID: 10227594
[TBL] [Abstract][Full Text] [Related]
11. Endocervical glandular involvement is associated with an increased detection rate of high-grade squamous intraepithelial lesions on the Papanicolaou test.
Jones R; Dale F; Fite JJ; Cowan ML; Williamson B; DeLuca J; VandenBussche CJ
J Am Soc Cytopathol; 2020; 9(3):137-145. PubMed ID: 32147423
[TBL] [Abstract][Full Text] [Related]
12. Relative risk of high grade squamous intraepithelial lesion associated with prior abnormal Pap smears.
Collins LC; Niloff J; Burke L; Abu-Jawdeh G; Wang H
J Reprod Med; 2001 Feb; 46(2):105-9. PubMed ID: 11255808
[TBL] [Abstract][Full Text] [Related]
13. High grade squamous intraepithelial lesion (CIN 3) with extension into the endocervical clefts. Difficulty of cytologic differentiation from adenocarcinoma in situ.
Drijkoningen M; Meertens B; Lauweryns J
Acta Cytol; 1996; 40(5):889-94. PubMed ID: 8842162
[TBL] [Abstract][Full Text] [Related]
14. Papanicolaou smear history in women with low-grade cytology before cervical cancer diagnosis.
Bofin AM; Nygård JF; Skare GB; Dybdahl BM; Westerhagen U; Sauer T
Cancer; 2007 Aug; 111(4):210-6. PubMed ID: 17567833
[TBL] [Abstract][Full Text] [Related]
15. Cytology and curetting diagnosis of endocervical adenocarcinoma.
Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
[TBL] [Abstract][Full Text] [Related]
16. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix.
Nieh S; Chen SF; Chu TY; Lai HC; Fu E
Gynecol Oncol; 2003 Oct; 91(1):201-8. PubMed ID: 14529682
[TBL] [Abstract][Full Text] [Related]
17. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases.
Lee KR; Minter LJ; Granter SR
Am J Clin Pathol; 1997 Jan; 107(1):30-5. PubMed ID: 8980364
[TBL] [Abstract][Full Text] [Related]
18. Cytologic findings in stratified mucin-producing intraepithelial lesion of the cervix: A report of 34 cases.
Backhouse A; Stewart CJ; Koay MH; Hunter A; Tran H; Farrell L; Ruba S
Diagn Cytopathol; 2016 Jan; 44(1):20-5. PubMed ID: 26493276
[TBL] [Abstract][Full Text] [Related]
19. ASCUS and AGUS criteria. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Solomon D; Frable WJ; Vooijs GP; Wilbur DC; Amma NS; Collins RJ; Davey DD; Knight BK; Luff RD; Meisels A; Navin J; Rosenthal DL; Sauer T; Stoler M; Suprun HZ; Yamauchi K
Acta Cytol; 1998; 42(1):16-24. PubMed ID: 9479320
[TBL] [Abstract][Full Text] [Related]
20. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
